Long before couples notice that they have grown apart, something changes. Here’s how small habits that stabilize connection ...

Docherty pulled from Carlton function after leaked voice message Carlton has yanked Sam Docherty from a booking at a Thursday night pre-game club function following his searing leaked audio message ...

Rule 82 allows assessees to determine arm’s length price for two additional consecutive years in a single transfer pricing proceeding, provided strict similarity and compliance conditions are ...

An informational overview of the QuickBurn BHB exogenous ketone supplement - ingredients, BHB salt research, potential side effects, ketosis claims, and what to verify before ordering.

Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...

The College Council of Cape Town has formally accused Minister Buti Manamela of unlawful conduct in appointing an administrator, raising serious concerns about governance and the future of over 10,000 ...

The Tribunal admitted the insolvency petition after determining that the borrower failed to repay outstanding dues despite ...

Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict Alzheimer's disease with nearly 93% accuracy.

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data at ...

Crypto is embedded in Russia’s procurement model, allowing it an access to Common High Priority Items that international sanctions were intended to deny. Huge disruption is necessary to apply pressure ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease- -Data support ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI ® (encorafenib) in combination with cetuximab ...